Product image of Mannitol Fresenius Kabi (Mannitol) supplied by GNH India

Mannitol Fresenius Kabi

Active Ingredient:
Mannitol
Origin:
EU

Mannitol Fresenius Kabi (Mannitol)

Mannitol, the active ingredient in Mannitol Fresenius Kabi, is an osmotic diuretic presented as an intravenous solution for intravenous use. It reduces intracranial and intra‑ocular pressure, treats cerebral edema, and promotes diuresis in acute renal failure.

GNH India supplies Mannitol Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company ensures quality and regulatory compliance across EU and global markets. Products are shipped with appropriate temperature control and documentation to meet import requirements.

Manufacturer / TM Owner

Fresenius Kabi Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mannitol is used as an osmotic diuretic to manage conditions involving elevated fluid pressure.

  • Reduction of intracranial pressure: lowers pressure within the skull to prevent brain injury.
  • Treatment of cerebral edema: reduces brain swelling caused by trauma or surgery.
  • Promotion of diuresis in acute renal failure: increases urine output to aid kidney function.
  • Reduction of intra‑ocular pressure: helps control pressure in glaucoma or ocular surgery.
  • Renal protection during nephrotoxic procedures: safeguards kidney function during contrast imaging.

How It Works

  • Mannitol acts as an osmotically active agent that is filtered by the glomeruli but poorly reabsorbed in the renal tubules. The resulting osmotic gradient draws water into the tubular lumen, increasing urinary flow and reducing fluid volume in the extracellular space, which in turn lowers intracranial and intra‑ocular pressures and facilitates renal clearance of toxins.

Side Effects

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Headache: mild to moderate discomfort.
  • Nausea or vomiting: gastrointestinal upset.
  • Electrolyte imbalance: especially hyponatremia or hypokalemia.
  • Hypotension: drop in blood pressure during rapid infusion.
  • Tachycardia: increased heart rate.
  • Thirst or dry mouth.

Serious or Rare Side Effects

  • Pulmonary edema: fluid accumulation in the lungs.
  • Severe electrolyte disturbances: hyperkalemia or hypernatremia.
  • Anaphylactic reaction: rare allergic response.
  • Acute renal failure worsening: especially in volume‑depleted patients.
  • Hemolysis: breakdown of red blood cells.
  • Metabolic acidosis: disturbance in blood pH.

Precautions & Warnings

Mannitol should be used with careful clinical monitoring to avoid complications.

  • Monitor electrolytes: check serum sodium, potassium, and osmolality regularly.
  • Assess renal function: evaluate creatinine and urine output before and during therapy.
  • Use caution in heart failure: avoid fluid overload.
  • Avoid rapid infusion in hypovolemia: infuse slowly to prevent hypotension.
  • Contraindicated in severe dehydration: ensure adequate volume status.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Mannitol can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Loop diuretics: may cause profound electrolyte loss.
  • ACE inhibitors or ARBs: increase risk of hypotension.
  • Lithium: osmotic effect can raise lithium levels.
  • Antihypertensives: additive blood pressure lowering.
  • Other osmotic agents: excess osmolar load.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may reduce diuretic efficacy.
  • Corticosteroids: can exacerbate fluid retention.
  • Anticonvulsants: monitor for altered serum concentrations.
  • Diabetic medications: watch for changes in glucose control.

Frequently Asked Questions

Mannitol is an osmotic diuretic administered intravenously to lower intracranial and intra‑ocular pressure, treat cerebral edema, promote urine output in acute renal failure, and protect the kidneys during procedures that involve nephrotoxic agents.

Mannitol creates an osmotic gradient in the renal tubules and extracellular fluid. Because it is filtered but not reabsorbed, water follows the solute into the urine, increasing diuresis and reducing fluid volume in the brain and eye, thereby lowering pressure.

The prescribed dose of Mannitol is individualized by the treating clinician based on the specific indication, patient weight, renal function, and desired osmotic effect. Dosing regimens are adjusted according to clinical response and laboratory monitoring.

Mannitol is classified as pregnancy category unknown. Because safety data are limited, it should only be used during pregnancy or lactation when the potential benefit justifies any potential risk, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Mannitol is the most widely used osmotic agent because of its rapid onset, predictable renal excretion, and ability to lower both intracranial and intra‑ocular pressure. Compared with agents such as hypertonic saline, Mannitol offers a clearer dosing profile and is less likely to cause hypernatremia when administered correctly.

Mannitol intravenous solution should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and allow the product to reach room temperature if required for infusion.

Mannitol is given by intravenous infusion. The rate of administration is determined by the prescriber and may be adjusted based on patient response, hemodynamic status, and laboratory values. Infusion sets should be compatible with the solution, and the line should be flushed before and after administration.

Serious risks include pulmonary edema, severe electrolyte disturbances (such as hypernatremia or hyperkalemia), anaphylactic reactions, and worsening renal failure in patients who are volume‑depleted. Prompt recognition of these events and immediate medical intervention are essential.

Mannitol is contraindicated in patients with severe dehydration, active intracranial hemorrhage where increased osmolarity could worsen bleeding, uncontrolled heart failure, and those with known hypersensitivity to the product. Clinicians should evaluate each patient’s clinical status before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.